As of 2025-11-02, the EV/EBITDA ratio of MEI Pharma Inc (MEIP) is -4.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MEIP's latest enterprise value is 91.73 mil USD. MEIP's TTM EBITDA according to its financial statements is -21.71 mil USD. Dividing these 2 quantities gives us the above MEIP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.8x - 15.2x | 15.1x |
| Forward P/E multiples | 16.9x - 24.9x | 19.0x |
| Fair Price | (10.06) - 13.02 | (0.51) |
| Upside | -427.6% - 324.0% | -116.7% |
| Date | EV/EBITDA |